Synergistic effect of kanamycin and amikacin with setomimycin on biofilm formation inhibition of Listeria monocytogenes
Microbial Pathogenesis · 2023
DOI: 10.1016/j.micpath.2023.106447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023. Verfasst von Wei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China…. Hauptthemen laut MEDLINE: Listeria monocytogenes, Listeriosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province.
Abstract (Originalsprache)
Listeria monocytogenes, a foodborne pathogen that causes listeriosis with high fatality rate, exhibits multidrug resistance (MDR) known to be progressively increasing. Alternative antibacterial strategies are in high demand for treating this well-known pathogen. Anti-biofilm and anti-virulence strategies are being explored as novel approaches to treat bacterial infections. In this study, one rare antibacterial named setomimycin was isolated from Streptomyces cyaneochromogenes, which showed potent antibacterial activity against L. monocytogenes. Next, the inhibition of biofilm formation and listeriolysin O (LLO) production against L. monocytogenes were investigated at sub-minimal inhibitory concentrations (sub-MICs) of setomimycin alone or combined with kanamycin and amikacin. Crystal violet staining confirmed that setomimycin combining with kanamycin or amikacin could dramatically reduce biofilm formation against L. monocytogenes at sub-MICs, which was further evaluated by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). In the meantime, sub-MICs of setomimycin could significantly suppress the secretion of LLO. Furthermore, the transcription of genes associated with biofilms and main virulence factors, such as LLO, flagellum, and metalloprotease, were suppressed by setomimycin at sub-MICs. Hence, the study provided a deep insight into setomimycin as an alternative antibacterial agent against L. monocytogenes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medica…
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.
- School of Food and Biological Engineering, Xuzhou University of Technology, Xuzhou, 221018, China.
- Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, China. Electronic address: aqjia@hainmc.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
Zitieren
APA
Wang, W., Liu, J. S., Zhou, J. W., & Jia, A. Q. (2023). Synergistic effect of kanamycin and amikacin with setomimycin on biofilm formation inhibition of Listeria monocytogenes. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106447
Vancouver
Wang W, Liu JS, Zhou JW, Jia AQ. Synergistic effect of kanamycin and amikacin with setomimycin on biofilm formation inhibition of Listeria monocytogenes. Microbial Pathogenesis. 2023. doi:10.1016/j.micpath.2023.106447
BibTeX
@article{Wang2023,
author = {Wang, Wei and Liu, Jun-Sheng and Zhou, Jin-Wei and Jia, Ai-Qun},
title = {Synergistic effect of kanamycin and amikacin with setomimycin on biofilm formation inhibition of Listeria monocytogenes},
journal = {Microbial Pathogenesis},
year = {2023},
doi = {10.1016/j.micpath.2023.106447}
}
EUVIMED